1. P1506: REAL-WORLD DATA ON THE USE OF LUSPATERCEPT IN GREEK PATIENTS WITH TRANSFUSION DEPENDENT THALASSEMIA. (23rd June 2022) Authors: Delaporta, P.; Delicou, S.; Kouraklis-Symeonidis, A.; Diamantidis, M.; Vlachaki, E.; Xydaki, A.; Labropoulou, V.; Lazaris, V.; Michalitsis, M.; Klonizakis, P.; Toutoudaki, K.; Chatzieleftheriou, M.-I.; Kyriakopoulou, D.; Kattamis, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1387 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1508: LUSPATERCEPT REDUCES THE BURDEN OF RED BLOOD CELL TRANSFUSION IN PATIENTS WITH BETA -THALASSEMIA AND COMORBIDITIES: THE EXPERIENCE OF A SINGLE THALASSEMIA AND SICKLE CELL UNIT IN A UNIVERSITY HOSPITAL. (23rd June 2022) Authors: Delicou, S.; Triantafyllou, M.; Xydaki, A.; Savvidis, C.; Aggeli, K.; Koskinas, I. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1389 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗